title: Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?
authors: G B
authors: GB
authors: Migliori
authors: C
authors: C
authors: Lange
authors: E
authors: E
authors: Girardi
authors: R
authors: R
authors: Centis
authors: G
authors: G
authors: Besozzi
authors: K
authors: K
authors: Kliiman
authors: L R
authors: LR
authors: Codecasa
authors: A
authors: A
authors: Spanevello
authors: D M
authors: DM
authors: Cirillo
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004957:Estonia / Q000453:epidemiology; D024841:Fluoroquinolones / Q000494:pharmacology / Q000627:therapeutic use*; D005858:Germany / Q000453:epidemiology; D006801:Humans; D007558:Italy / Q000453:epidemiology; D012307:Risk Factors; D012426:Russia / Q000453:epidemiology; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy* / Q000401:mortality
chemical_list: D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones